Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C038237 |
1-oleoyl-2-acetylglycerol |
1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
C038237 |
1-oleoyl-2-acetylglycerol |
1-oleoyl-2-acetylglycerol results in increased phosphorylation of and results in decreased expression of ABCA1 protein | decreases expression|increases phosphorylation | 16118212
|
C003585 |
22-hydroxycholesterol |
22-hydroxycholesterol results in increased expression of ABCA1 mRNA | increases expression | 16142410 19426978 16730733
|
C028358 |
24,25-epoxycholesterol |
24,25-epoxycholesterol results in increased expression of ABCA1 mRNA | increases expression | 19426978
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ABCA1 mRNA | affects expression | 21346803
|
C044563 |
24-hydroxycholesterol |
24-hydroxycholesterol results in increased expression of ABCA1 mRNA | increases expression | 15148325
|
C044563 |
24-hydroxycholesterol |
24-hydroxycholesterol results in increased expression of ABCA1 protein | increases expression | 19126211
|
C007997 |
25-hydroxycholesterol |
[25-hydroxycholesterol co-treated with alitretinoin] results in increased expression of ABCA1 protein | affects cotreatment|increases expression | 16023994
|
C007997 |
25-hydroxycholesterol |
[Cholesterol co-treated with 25-hydroxycholesterol] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 17526932
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ABCA1 mRNA | affects expression | 21346803
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased expression of ABCA1 mRNA | increases expression | 18841091 15148325
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased expression of ABCA1 protein | increases expression | 17088262
|
C076996 |
27-hydroxycholesterol |
[fingolimod results in increased abundance of 27-hydroxycholesterol] which results in increased expression of ABCA1 mRNA | increases abundance|increases expression | 20056921
|
C076996 |
27-hydroxycholesterol |
27-hydroxycholesterol results in increased expression of ABCA1 mRNA | increases expression | 18356535
|
C076996 |
27-hydroxycholesterol |
Docosahexaenoic Acids inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 18356535
|
C076996 |
27-hydroxycholesterol |
Linoleic Acid inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 18356535
|
C076996 |
27-hydroxycholesterol |
Oleic Acid inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 18356535
|
C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 mRNA] | decreases expression|decreases reaction | 17070507
|
C010643 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 protein] | decreases expression|decreases reaction | 17070507
|
C046938 |
9,11-linoleic acid |
9,11-linoleic acid results in increased expression of ABCA1 mRNA | increases expression | 15778275
|
D000242 |
Cyclic AMP |
Cyclic AMP results in increased expression of ABCA1 mRNA | increases expression | 20339114
|
D000242 |
Cyclic AMP |
Cyclic AMP results in increased expression of ABCA1 protein | increases expression | 20339114
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ABCA1 protein | affects expression | 20106945
|
C096920 |
AGN 193109 |
AGN 193109 inhibits the reaction [Tretinoin results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 16505366
|
C103303 |
alitretinoin |
[25-hydroxycholesterol co-treated with alitretinoin] results in increased expression of ABCA1 protein | affects cotreatment|increases expression | 16023994
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ABCA1 mRNA | affects expression | 16483693
|
D016718 |
Arachidonic Acid |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D016718 |
Arachidonic Acid |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D016718 |
Arachidonic Acid |
Arachidonic Acid results in increased degradation of ABCA1 protein | increases degradation | 16118212
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ABCA1 mRNA | decreases expression | 20339114 20458559
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ABCA1 protein | decreases expression | 20339114
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ABCA1 mRNA | decreases expression | 20339114
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ABCA1 protein | decreases expression | 20339114
|
D001205 |
Ascorbic Acid |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 17639512
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of ABCA1 mRNA | decreases expression | 20106945
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of ABCA1 mRNA | increases expression | 18180321
|
D020001 |
1-Butanol |
1-Butanol inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol]] | decreases reaction|increases export | 16118212
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene co-treated with iron(II)-ascorbic acid complex] results in increased expression of ABCA1 protein | affects cotreatment|increases expression | 17070507
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 mRNA] | decreases expression|decreases reaction | 17070507
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 protein] | decreases expression|decreases reaction | 17070507
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in increased expression of ABCA1 mRNA | increases expression | 17070507
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of ABCA1 mRNA | increases expression | 15336504
|
D002784 |
Cholesterol |
1-Butanol inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol]] | decreases reaction|increases export | 16118212
|
D002784 |
Cholesterol |
1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
ABCA1 protein results in increased export of Cholesterol | increases export | 15983222
|
D002784 |
Cholesterol |
ABCA1 protein results in increased transport of Cholesterol | increases transport | 16118212
|
D002784 |
Cholesterol |
APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol] | affects reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
APOA1 protein promotes the reaction [ABCA1 protein results in increased export of Cholesterol] | increases export|increases reaction | 15983222
|
D002784 |
Cholesterol |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
glycolaldehyde inhibits the reaction [ABCA1 protein results in increased export of Cholesterol] | decreases reaction|increases export | 15983222
|
D002784 |
Cholesterol |
Glyoxal inhibits the reaction [ABCA1 protein results in increased export of Cholesterol] | decreases reaction|increases export | 15983222
|
D002784 |
Cholesterol |
Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol] | decreases reaction|increases export | 16118212
|
D002784 |
Cholesterol |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
mastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]] | affects reaction|decreases reaction|increases export | 16118212
|
D002784 |
Cholesterol |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
PLD2 protein affects the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]] | affects reaction|increases export | 16118212
|
D002784 |
Cholesterol |
PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]] | affects reaction|decreases reaction|increases export | 16118212
|
D002784 |
Cholesterol |
triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Cholesterol]] | decreases reaction|increases transport | 16118212
|
D002784 |
Cholesterol |
Cholesterol results in increased expression of ABCA1 mRNA | increases expression | 15342687
|
D002784 |
Cholesterol |
ABCA1 protein affects the export of Cholesterol | affects export | 14993927
|
D002784 |
Cholesterol |
[Cholesterol co-treated with Dietary Fats] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 15694933
|
D002784 |
Cholesterol |
[Cholesterol deficiency co-treated with Dietary Fats] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 18356535
|
D002784 |
Cholesterol |
[Cholesterol co-treated with 25-hydroxycholesterol] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 17526932
|
D002784 |
Cholesterol |
[[colestimide co-treated with Pravastatin] results in increased expression of ABCA1 protein] which results in decreased abundance of Cholesterol | affects cotreatment|decreases abundance|increases expression | 17526932
|
D002784 |
Cholesterol |
ABCA1 protein affects the transport of Cholesterol | affects transport | 15883047
|
D002791 |
Cholesterol, Dietary |
Cholesterol, Dietary results in increased expression of ABCA1 mRNA | increases expression | 19509184
|
D002791 |
Cholesterol, Dietary |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 19509184
|
D002791 |
Cholesterol, Dietary |
[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 14684380
|
D002791 |
Cholesterol, Dietary |
Cholesterol, Dietary results in increased expression of ABCA1 mRNA | increases expression | 14684380
|
D008076 |
Cholesterol, HDL |
ABCA1 gene polymorphism affects the abundance of Cholesterol, HDL | affects abundance | 16030523
|
D019826 |
Cholic Acid |
Cholic Acid results in increased expression of ABCA1 mRNA | increases expression | 15694933
|
D019826 |
Cholic Acid |
[Cholesterol, Dietary co-treated with Cholic Acid] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 14684380
|
D002994 |
Clofibrate |
Clofibrate results in increased expression of ABCA1 mRNA | increases expression | 14690017
|
D002994 |
Clofibrate |
Ketoconazole inhibits the reaction [Clofibrate results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 14690017
|
C417427 |
colestimide |
[colestimide co-treated with Pravastatin] affects the expression of ABCA1 mRNA | affects cotreatment|affects expression | 17526932
|
C417427 |
colestimide |
[colestimide co-treated with Pravastatin] affects the expression of ABCA1 protein | affects cotreatment|affects expression | 17526932
|
C417427 |
colestimide |
[[colestimide co-treated with Pravastatin] results in increased expression of ABCA1 protein] which results in decreased abundance of Cholesterol | affects cotreatment|decreases abundance|increases expression | 17526932
|
C012258 |
compactin |
compactin affects the expression of ABCA1 mRNA | affects expression | 17526932
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ABCA1 mRNA | decreases expression | 20106945
|
C004742 |
daidzein |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 16963248
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 16054899
|
D003994 |
Bucladesine |
[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 20083572
|
D003994 |
Bucladesine |
STAR protein promotes the reaction [[Bucladesine co-treated with APOA1 protein] results in increased expression of ABCA1 mRNA] | affects cotreatment|increases expression|increases reaction | 20083572
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 19509184
|
D004041 |
Dietary Fats |
[Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 19509184
|
D004041 |
Dietary Fats |
[Cholesterol co-treated with Dietary Fats] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 15694933
|
D004041 |
Dietary Fats |
[Cholesterol deficiency co-treated with Dietary Fats] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 18356535
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of ABCA1 mRNA | decreases expression | 18457598
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of ABCA1 mRNA | increases expression | 16002434
|
D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 18356535
|
D004281 |
Docosahexaenoic Acids |
Docosahexaenoic Acids results in increased expression of ABCA1 mRNA | increases expression | 18356535
|
D015118 |
Eicosapentaenoic Acid |
Eicosapentaenoic Acid results in decreased expression of ABCA1 mRNA | decreases expression | 16730733
|
D015118 |
Eicosapentaenoic Acid |
PPARA protein promotes the reaction [Eicosapentaenoic Acid results in increased expression of ABCA1 mRNA] | increases expression|increases reaction | 18489776
|
D004958 |
Estradiol |
Estradiol results in decreased expression of ABCA1 mRNA | decreases expression | 20106945
|
C108606 |
ezetimibe |
ezetimibe results in decreased expression of ABCA1 mRNA | decreases expression | 16177187
|
D005227 |
Fatty Acids |
Fatty Acids results in increased degradation of ABCA1 protein | increases degradation | 16118212
|
D005227 |
Fatty Acids |
triacsin C inhibits the reaction [Fatty Acids results in increased degradation of ABCA1 protein] | decreases reaction|increases degradation | 16118212
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated results in decreased expression of ABCA1 mRNA | decreases expression | 18356535
|
C098720 |
fingolimod |
[fingolimod results in increased abundance of 27-hydroxycholesterol] which results in increased expression of ABCA1 mRNA | increases abundance|increases expression | 20056921
|
C098720 |
fingolimod |
fingolimod results in increased expression of ABCA1 mRNA | increases expression | 20056921
|
C098720 |
fingolimod |
fingolimod results in increased expression of ABCA1 protein | increases expression | 20056921
|
C098720 |
fingolimod |
NPC1 protein affects the reaction [fingolimod results in increased expression of ABCA1 protein] | affects reaction|increases expression | 20056921
|
C098720 |
fingolimod |
UVI 3003 inhibits the reaction [fingolimod results in increased expression of ABCA1 protein] | decreases reaction|increases expression | 20056921
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with Cholesterol, Dietary] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 19509184
|
D005632 |
Fructose |
[Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 19509184
|
D005632 |
Fructose |
Fructose results in increased expression of ABCA1 mRNA | increases expression | 19193814
|
D005632 |
Fructose |
Tea inhibits the reaction [Fructose results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 19193814
|
D019833 |
Genistein |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 16963248
|
D019833 |
Genistein |
Genistein results in increased expression of ABCA1 mRNA | increases expression | 18847459
|
C086566 |
glycitein |
[Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 16963248
|
C010972 |
glycolaldehyde |
glycolaldehyde inhibits the reaction [ABCA1 protein results in increased export of Cholesterol] | decreases reaction|increases export | 15983222
|
C010972 |
glycolaldehyde |
glycolaldehyde inhibits the reaction [ABCA1 protein binds to APOA1 protein] | affects binding|decreases reaction | 15983222
|
C010972 |
glycolaldehyde |
glycolaldehyde results in increased degradation of ABCA1 protein | increases degradation | 15983222
|
D006037 |
Glyoxal |
Glyoxal inhibits the reaction [ABCA1 protein results in increased export of Cholesterol] | decreases reaction|increases export | 15983222
|
D006037 |
Glyoxal |
Glyoxal inhibits the reaction [ABCA1 protein binds to APOA1 protein] | affects binding|decreases reaction | 15983222
|
D006037 |
Glyoxal |
Glyoxal results in increased degradation of ABCA1 protein | increases degradation | 15983222
|
C504517 |
GSK 3987 |
GSK 3987 results in increased expression of ABCA1 mRNA | increases expression | 16107141
|
C473027 |
GW 3965 |
GW 3965 results in increased expression of ABCA1 mRNA | increases expression | 16107141 17449538 18841091 19426978
|
C473027 |
GW 3965 |
GW 3965 results in increased expression of ABCA1 mRNA | increases expression | 15633131
|
C051140 |
iron(II)-ascorbic acid complex |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 mRNA] | decreases expression|decreases reaction | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 protein] | decreases expression|decreases reaction | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
[Butylated Hydroxytoluene co-treated with iron(II)-ascorbic acid complex] results in increased expression of ABCA1 protein | affects cotreatment|increases expression | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 mRNA] | decreases expression|decreases reaction | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of ABCA1 protein] | decreases expression|decreases reaction | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
iron(II)-ascorbic acid complex promotes the reaction [Malondialdehyde results in increased expression of ABCA1 protein] | increases expression|increases reaction | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
iron(II)-ascorbic acid complex results in decreased expression of ABCA1 mRNA | decreases expression | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
iron(II)-ascorbic acid complex results in decreased expression of ABCA1 protein | decreases expression | 17070507
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 16054899
|
D007654 |
Ketoconazole |
Ketoconazole inhibits the reaction [Clofibrate results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 14690017
|
C440499 |
lipopolysaccharide, Escherichia coli 0111 B4 |
lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of ABCA1 mRNA | decreases expression | 12010990
|
C440499 |
lipopolysaccharide, Escherichia coli 0111 B4 |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of ABCA1 mRNA] | decreases expression|decreases reaction | 12010990
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of ABCA1 mRNA | decreases expression | 16847310
|
D008095 |
Lithocholic Acid |
Lithocholic Acid results in decreased expression of ABCA1 mRNA | decreases expression | 15883047
|
D008095 |
Lithocholic Acid |
Lithocholic Acid results in decreased expression of ABCA1 protein | decreases expression | 15883047
|
D008315 |
Malondialdehyde |
iron(II)-ascorbic acid complex promotes the reaction [Malondialdehyde results in increased expression of ABCA1 protein] | increases expression|increases reaction | 17070507
|
C037500 |
mastoparan |
mastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]] | affects reaction|decreases reaction|increases export | 16118212
|
C037500 |
mastoparan |
mastoparan results in increased phosphorylation of ABCA1 protein | increases phosphorylation | 16118212
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of ABCA1 mRNA | decreases expression | 20713471
|
D008942 |
Mitoxantrone |
ABCA1 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
D019787 |
Linoleic Acid |
1-Butanol inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol]] | decreases reaction|increases export | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid inhibits the reaction [ABCA1 protein results in increased export of Cholesterol] | decreases reaction|increases export | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid results in increased degradation of ABCA1 protein | increases degradation | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid results in increased phosphorylation of ABCA1 protein | increases phosphorylation | 16118212
|
D019787 |
Linoleic Acid |
PLD2 protein inhibits the reaction [Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of Cholesterol]]] | affects reaction|decreases reaction|increases export | 16118212
|
D019787 |
Linoleic Acid |
triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Cholesterol]] | decreases reaction|increases transport | 16118212
|
D019787 |
Linoleic Acid |
triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Phospholipids]] | decreases reaction|increases transport | 16118212
|
D019787 |
Linoleic Acid |
triacsin C inhibits the reaction [Linoleic Acid results in increased degradation of ABCA1 protein] | decreases reaction|increases degradation | 16118212
|
D019787 |
Linoleic Acid |
Linoleic Acid inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 18356535
|
D019787 |
Linoleic Acid |
Linoleic Acid results in increased expression of ABCA1 mRNA | increases expression | 18356535
|
D019301 |
Oleic Acid |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019301 |
Oleic Acid |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D019301 |
Oleic Acid |
Oleic Acid results in increased degradation of ABCA1 protein | increases degradation | 16118212
|
D019301 |
Oleic Acid |
Oleic Acid results in increased phosphorylation of ABCA1 protein | increases phosphorylation | 16118212
|
D019301 |
Oleic Acid |
Oleic Acid inhibits the reaction [27-hydroxycholesterol results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 18356535
|
D019301 |
Oleic Acid |
Oleic Acid results in increased expression of ABCA1 mRNA | increases expression | 18356535
|
D010126 |
Ozone |
Ozone results in decreased expression of ABCA1 mRNA | decreases expression | 16183385
|
C008757 |
palmitoleic acid |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Cholesterol]] | affects reaction|decreases reaction|increases transport | 16118212
|
C008757 |
palmitoleic acid |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
C008757 |
palmitoleic acid |
palmitoleic acid results in increased degradation of ABCA1 protein | increases degradation | 16118212
|
C008757 |
palmitoleic acid |
palmitoleic acid results in increased phosphorylation of ABCA1 protein | increases phosphorylation | 16118212
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ABCA1 mRNA | increases expression | 17681415
|
D010672 |
Phenytoin |
Phenytoin results in decreased expression of ABCA1 mRNA | decreases expression | 15136057
|
D010743 |
Phospholipids |
ABCA1 protein results in increased transport of Phospholipids | increases transport | 16118212
|
D010743 |
Phospholipids |
APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids] | affects reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
Arachidonic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
Linoleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
Oleic Acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of Phospholipids]] | affects reaction|decreases reaction|increases transport | 16118212
|
D010743 |
Phospholipids |
triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Phospholipids]] | decreases reaction|increases transport | 16118212
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ABCA1 mRNA | affects binding|increases activity|increases expression | 18489776
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ABCA1 mRNA | increases expression | 18301758 18445702 17426115
|
D017035 |
Pravastatin |
[colestimide co-treated with Pravastatin] affects the expression of ABCA1 mRNA | affects cotreatment|affects expression | 17526932
|
D017035 |
Pravastatin |
[colestimide co-treated with Pravastatin] affects the expression of ABCA1 protein | affects cotreatment|affects expression | 17526932
|
D017035 |
Pravastatin |
[[colestimide co-treated with Pravastatin] results in increased expression of ABCA1 protein] which results in decreased abundance of Cholesterol | affects cotreatment|decreases abundance|increases expression | 17526932
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in decreased expression of ABCA1 mRNA | decreases expression | 15883047
|
D011285 |
Pregnenolone Carbonitrile |
Pregnenolone Carbonitrile results in decreased expression of ABCA1 protein | decreases expression | 15883047
|
D011341 |
Probucol |
Probucol results in decreased activity of ABCA1 protein | decreases activity | 20083572
|
D011794 |
Quercetin |
[Quercetin co-treated with Ascorbic Acid] results in decreased expression of ABCA1 mRNA | affects cotreatment|decreases expression | 17639512
|
C059514 |
resveratrol |
resveratrol results in increased expression of ABCA1 mRNA | increases expression | 16901463
|
D012293 |
Rifampin |
Rifampin results in decreased expression of ABCA1 mRNA | decreases expression | 15883047
|
D012293 |
Rifampin |
Rifampin results in decreased expression of ABCA1 protein | decreases expression | 15883047
|
D012293 |
Rifampin |
Rifampin results in increased expression of ABCA1 mRNA | increases expression | 17088262
|
D012293 |
Rifampin |
Rifampin results in increased expression of ABCA1 protein | increases expression | 17088262
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 16054899
|
D013662 |
Tea |
Tea inhibits the reaction [Fructose results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 19193814
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of ABCA1 mRNA | increases expression | 16917069
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of ABCA1 mRNA | increases expression | 19426978 15548517 20056921 17449538 16142410 18841091
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of ABCA1 protein | increases expression | 17088262
|
C423915 |
TO-901317 |
[Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of ABCA1 mRNA | affects cotreatment|increases expression | 19509184
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of ABCA1 mRNA | increases expression | 17526932 19665519
|
D014050 |
Toluene |
Toluene affects the expression of ABCA1 mRNA | affects expression | 18653662
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in decreased expression of ABCA1 mRNA] | decreases expression|decreases reaction | 12010990
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of ABCA1 mRNA | decreases expression | 17951470
|
D014212 |
Tretinoin |
AGN 193109 inhibits the reaction [Tretinoin results in increased expression of ABCA1 mRNA] | decreases reaction|increases expression | 16505366
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ABCA1 mRNA | increases expression | 16505366
|
C034613 |
triacsin C |
triacsin C inhibits the reaction [Fatty Acids results in increased degradation of ABCA1 protein] | decreases reaction|increases degradation | 16118212
|
C034613 |
triacsin C |
triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Cholesterol]] | decreases reaction|increases transport | 16118212
|
C034613 |
triacsin C |
triacsin C inhibits the reaction [Linoleic Acid inhibits the reaction [ABCA1 protein results in increased transport of Phospholipids]] | decreases reaction|increases transport | 16118212
|
C034613 |
triacsin C |
triacsin C inhibits the reaction [Linoleic Acid results in increased degradation of ABCA1 protein] | decreases reaction|increases degradation | 16118212
|
C009564 |
trilinolein |
trilinolein results in decreased expression of ABCA1 mRNA | decreases expression | 18356535
|
C101314 |
trilinolenin |
trilinolenin results in decreased expression of ABCA1 mRNA | decreases expression | 18356535
|
D014304 |
Triolein |
Triolein results in decreased expression of ABCA1 mRNA | decreases expression | 18356535
|
C525131 |
UVI 3003 |
UVI 3003 inhibits the reaction [fingolimod results in increased expression of ABCA1 protein] | decreases reaction|increases expression | 20056921
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
3.71 | 10563481 8986270 6195326 9677735 9118846 3425630 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.77 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.14 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
6.58 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
6.58 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
10.42 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
10.42 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
daidzein |
10.42 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
10.42 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
10.42 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
8.23 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
8.23 | 6695378 10545420 |
MESH:D000236 |
Adenoma |
|
resveratrol |
8.23 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
2.69 | 16434500 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
2.96 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
24-hydroxycholesterol |
12.34 | 14523054 |
MESH:D000544 |
Alzheimer Disease |
|
27-hydroxycholesterol |
12.34 | 20157255 14523054 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
12.34 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
12.34 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
12.34 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
12.34 | 19621015 |
MESH:D000740 |
Anemia |
|
Malondialdehyde |
4.86 | 17278206 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.51 | 17084956 |
MESH:D000860 |
Anoxia |
|
Oleic Acid |
5.10 | 15090967 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.29 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
9,11-linoleic acid |
13.07 | 15778275 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
13.07 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
13.07 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
13.12 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
13.12 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
13.12 | 18706406 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
13.12 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
3.76 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
3.76 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
3.86 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
3.86 | 16456186 |
MESH:D001259 |
Ataxia |
|
1-Butanol |
4.84 | 7820390 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.18 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
27-hydroxycholesterol |
18.80 | 11166758 9059518 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
18.80 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
fingolimod |
18.80 | 20056921 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
18.80 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
18.80 | 15136057 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
18.80 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Arachidonic Acid |
2.51 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Docosahexaenoic Acids |
2.51 | 18582451 |
MESH:D001321 |
Autistic Disorder |
|
Linoleic Acid |
2.51 | 18582451 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
3.63 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
16.09 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
16.09 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
16.09 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
16.09 | 16197459 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.14 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.49 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
7.72 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Ascorbic Acid |
7.72 | 16443354 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
7.72 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
7.72 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
7.72 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
7.72 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
7.72 | 17261762 12948864 17289903 18497071 17018787 14630087 19861407 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
7.72 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
7.72 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
7.72 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
7.72 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
7.72 | 16873071 16443354 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.03 | 15516495 14754758 16777450 19059883 18417511 18315731 17626835 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
3.79 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.58 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
3.94 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.73 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.66 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
3.32 | 10545420 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.34 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
15.74 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
15.74 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
15.74 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
15.74 | 16217749 15553829 15073043 11135700 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
15.74 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
15.74 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
15.74 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
15.74 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
15.74 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.19 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.79 | 16675471 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.17 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.06 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.41 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
8.12 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
8.12 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
8.12 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
8.12 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
2.82 | 19794523 |
MESH:D002318 |
Cardiovascular Diseases |
|
daidzein |
8.91 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
8.91 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
8.91 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.57 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
14.84 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
14.84 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.84 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.84 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
14.84 | 16192471 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
4.52 | 4080065 |
MESH:D002547 |
Cerebral Palsy |
|
Toluene |
5.05 | 9294310 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.79 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
10.03 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Lithocholic Acid |
10.03 | 19965603 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
10.03 | 19176532 |
MESH:C535930 |
Cholestasis, benign recurrent intrahepatic 1 |
|
colestimide |
7.13 | 18379143 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
5.07 | 11748493 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.34 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
3.67 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
4.98 | 2227380 6862529 6856622 1687470 3877104 10789828 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.98 | 9407595 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.05 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
7.05 | 17035595 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
4.42 | 9212184 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
6.41 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
6.41 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
6.41 | 15741050 11134977 17148506 19056647 19440933 17191121 16640504 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
6.41 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.88 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
2.88 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.88 | 16550006 |
MESH:D003139 |
Common Cold |
|
Ascorbic Acid |
4.66 | 17323712 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
4.01 | 10627286 |
MESH:D003327 |
Coronary Disease |
marker/mechanism |
|
| |
MESH:D003327 |
Coronary Disease |
|
Fructose |
6.89 | 18504504 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
6.89 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.42 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.81 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
5.81 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
5.81 | 19952982 9212184 8986270 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Toluene |
5.81 | 9294310 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.81 | 16925845 9125849 9211117 10589399 9142499 14991402 9224671 9664655 8800419 17551590 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.30 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.30 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Docosahexaenoic Acids |
3.98 | 19747007 |
MESH:D003643 |
Death |
|
Toluene |
4.85 | 6431079 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.35 | 15213294 |
MESH:D003715 |
Dengue |
|
24-hydroxycholesterol |
9.54 | 19427377 |
MESH:D003715 |
Dengue |
|
27-hydroxycholesterol |
9.54 | 19427377 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.69 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
1.99 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
3.61 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Fructose |
10.23 | 18603373 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
10.23 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
10.23 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Ascorbic Acid |
10.62 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
daidzein |
10.62 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Fructose |
10.62 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
10.62 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
10.62 | 12642470 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
6.73 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
6.73 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
2.97 | 7237001 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
4.61 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
4.72 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.61 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.61 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ketoconazole |
8.61 | 18289764 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tea |
8.61 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
8.61 | 17522070 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
6.77 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
6.77 | 18367378 |
MESH:C538011 |
Eales disease |
|
Ascorbic Acid |
4.66 | 9068938 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.70 | 12438553 |
MESH:D004487 |
Edema |
|
Arachidonic Acid |
17.86 | 15177302 11698051 9599246 9831321 7990266 16716910 |
MESH:D004487 |
Edema |
|
Dexamethasone |
17.86 | 19703484 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
17.86 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
17.86 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
17.86 | 8985016 |
MESH:D004487 |
Edema |
|
rosiglitazone |
17.86 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
3.65 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
24-hydroxycholesterol |
20.83 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
27-hydroxycholesterol |
20.83 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
20.83 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
20.83 | 17654737 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
20.83 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
3.79 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
daidzein |
13.13 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
13.13 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
13.13 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
13.13 | 16569247 |
MESH:D019446 |
Endotoxemia |
|
lipopolysaccharide, Escherichia coli 0111 B4 |
8.41 | 12954792 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
8.41 | 15821434 15328337 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.07 | 17923197 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
4.43 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
5.42 | 6251365 1399206 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
4.11 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
3.47 | 821787 20417680 11434505 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
4.52 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
4.27 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
daidzein |
4.26 | 14972507 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
3.48 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.48 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
2.95 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
30.75 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
30.75 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
30.75 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
30.75 | 17967931 19004024 18296743 19551842 |
MESH:D005234 |
Fatty Liver |
|
Fructose |
30.75 | 18395287 19196556 18641190 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
30.75 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
30.75 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
30.75 | 19224547 16917069 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
4.32 | 10627286 |
MESH:D005334 |
Fever |
|
Arachidonic Acid |
11.47 | 11852909 |
MESH:D005334 |
Fever |
|
lipopolysaccharide, Escherichia coli 0111 B4 |
11.47 | 16997862 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
11.47 | 11852909 9205823 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.14 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.60 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
19.60 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Fructose |
19.60 | 18504504 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
19.60 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
19.60 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.50 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
10.26 | 8708960 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
10.26 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
5.42 | 14659971 16390469 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
8.62 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
8.62 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
8.62 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.67 | 17643826 |
MESH:D018149 |
Glucose Intolerance |
|
Fructose |
4.58 | 19165636 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
2.60 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.34 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Ascorbic Acid |
8.41 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
8.41 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
8.41 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
3.56 | 16019553 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.00 | 20558911 |
MESH:D016481 |
Helicobacter Infections |
|
Malondialdehyde |
5.23 | 17278206 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.62 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.67 | 16366002 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
6.14 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
6.14 | 19772884 18467677 19176532 16221962 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Ascorbic Acid |
5.04 | 16490937 16863852 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
5.04 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.22 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.39 | 16876885 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
2.95 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
9.47 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
9.47 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
9.47 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
marker/mechanism |
|
| |
MESH:D006937 |
Hypercholesterolemia |
|
27-hydroxycholesterol |
31.71 | 17873880 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
31.71 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
31.71 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
31.71 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
ezetimibe |
31.71 | 17076980 15374793 |
MESH:D006937 |
Hypercholesterolemia |
|
Pravastatin |
31.71 | 17188708 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
31.71 | 17188708 |
OMIM:143890 |
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT |
marker/mechanism |
|
| |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.78 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
6.89 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
6.89 | 11834736 18262572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
3.98 | 10459572 |
MESH:D006946 |
Hyperinsulinism |
|
Fructose |
4.22 | 15752949 18563319 18360027 19008412 14757778 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
11.32 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Fructose |
11.32 | 15752949 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
11.32 | 16873680 |
MESH:D006951 |
Hyperlipoproteinemias |
|
Fatty Acids, Unsaturated |
5.46 | 18435438 |
MESH:D006938 |
Hyperlipoproteinemia Type II |
marker/mechanism |
|
| 16030523 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
3.81 | 17604070 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
12.27 | 10903974 |
MESH:D006973 |
Hypertension |
|
daidzein |
12.27 | 17169123 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
12.27 | 17042910 |
MESH:D006973 |
Hypertension |
|
Fructose |
12.27 | 14568997 16843071 19008412 14633139 14573337 |
MESH:D006973 |
Hypertension |
|
Quercetin |
12.27 | 18356687 |
MESH:D015228 |
Hypertriglyceridemia |
|
Fructose |
4.37 | 19342510 19799862 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.59 | 17488730 |
MESH:D052456 |
Hypoalphalipoproteinemias |
marker/mechanism |
|
| |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.63 | 18306037 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.87 | 17600658 |
MESH:D007249 |
Inflammation |
|
Arachidonic Acid |
16.78 | 17371808 15177302 9831321 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
16.78 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
16.78 | 20412841 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
16.78 | 12878042 17963957 17237260 17255318 9205823 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
16.78 | 12083418 |
MESH:D007249 |
Inflammation |
|
resveratrol |
16.78 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
16.78 | 12083418 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
8.50 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
8.50 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
21.53 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
21.53 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
21.53 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Fructose |
21.53 | 14573337 17133782 19008412 18981581 18563319 18057795 19586609 19342510 14633139 19799862 14757778 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
21.53 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
21.53 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
2.99 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
3.88 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.17 | 15992940 17551590 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
4.63 | 18306037 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.17 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.63 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
4.84 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
7.06 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
7.06 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
7.06 | 16962696 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Malondialdehyde |
5.13 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.28 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.28 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.28 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.28 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
4.32 | 17134702 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Ketoconazole |
4.03 | 1311351 2166429 19744259 8889330 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Ketoconazole |
3.92 | 11332679 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
11.07 | 15070760 |
MESH:D007938 |
Leukemia |
|
Genistein |
11.07 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
11.07 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
11.07 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.38 | 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
7.65 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Docosahexaenoic Acids |
7.65 | 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.51 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.80 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
7.07 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.07 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.16 | 16968895 16467208 19850784 20471514 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.16 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
9.45 | 15748426 19642359 11161223 16823087 16331271 17107899 19225113 17712046 12679006 16891316 16966277 12712474 15622746 15213294 17869043 17649720 19075265 11468182 15336539 12018890 16112521 16330433 9834237 17217047 19035177 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
9.45 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
9.45 | 16331271 17301526 16140955 16891316 9834237 19029980 15748426 17649720 16766008 17361223 17368321 16823087 17712046 12679006 17339181 17217047 19642359 16935935 19035177 17294898 19075265 19225113 17107899 17506722 16788101 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.59 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
3.90 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.43 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.70 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Ketoconazole |
3.96 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.38 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
10.31 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.31 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
10.31 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
10.31 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
10.31 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
10.31 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
10.31 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
10.31 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Docosahexaenoic Acids |
4.04 | 17056761 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
4.04 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
22.31 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
22.31 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
22.31 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.31 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
22.31 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
22.31 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.31 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
22.31 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
22.31 | 19073162 20405173 19321006 19812893 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
19.83 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
19.83 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
19.83 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Ascorbic Acid |
19.83 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
19.83 | 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Probucol |
19.83 | 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
19.83 | 19519916 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.72 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Ascorbic Acid |
5.86 | 16863852 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
5.86 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
10.95 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Oleic Acid |
10.95 | 15090967 |
MESH:D055370 |
Lung Injury |
|
Ozone |
10.95 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
14.23 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
14.23 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
14.23 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Ascorbic Acid |
14.23 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.23 | 20464547 20869020 18520028 20135361 17053015 18816296 20064080 6695378 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
14.23 | 11696405 15390079 19359593 16337739 19925653 11246140 18597497 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
14.23 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
14.23 | 16271038 16337739 17909032 1399818 9230183 20970405 20512841 15390079 10545420 11893704 6695378 7750092 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
14.23 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
14.23 | 16280456 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Rifampin |
5.33 | 11422169 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Rifampin |
3.68 | 11422169 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.56 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.20 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.46 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
12.89 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
12.89 | 11807958 17203775 16891317 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
12.89 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
12.89 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
12.89 | 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.67 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.39 | 17453147 |
MESH:D008545 |
Melanoma |
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid |
4.14 | 17992120 |
MESH:D008545 |
Melanoma |
|
resveratrol |
4.14 | 17992120 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
4.14 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.64 | 16940565 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
5.31 | 9212184 |
MESH:D008607 |
Mental Retardation |
|
Toluene |
5.31 | 9294310 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.65 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Fructose |
7.79 | 18497449 17098227 16815490 19165636 17261469 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
7.79 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
3.97 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.29 | 10496685 |
MESH:D020326 |
Migraine without Aura |
|
Cyclic AMP |
4.39 | 11304026 |
MESH:D019957 |
Motor Skills Disorders |
|
Toluene |
4.49 | 9294310 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.55 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
8.68 | 15949261 19549372 14977855 11468182 19417148 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
8.68 | 16118317 15744524 15867202 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
8.68 | 17049120 16267019 17164350 14749477 17935668 16490592 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.07 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.73 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
Rifampin |
4.74 | 18474467 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.86 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
9.32 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
9.32 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
9.32 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
13.48 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
13.48 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Pravastatin |
13.48 | 17188708 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
13.48 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
13.48 | 17188708 16525036 16456233 16317513 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
3.35 | 17015251 17125593 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
15.04 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
15.04 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
15.04 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
15.04 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.96 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
4.72 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
4.61 | 1896199 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
7.70 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
7.70 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.20 | 16624393 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
13.70 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
13.70 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
13.70 | 16640825 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
13.70 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
13.70 | 15185748 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
13.70 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.23 | 8985016 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
2.94 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
3.98 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.63 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.60 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
17.26 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
17.26 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
17.26 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
17.26 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
8.96 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
8.96 | 9118846 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
8.96 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.14 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.22 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.22 | 17929310 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
15.76 | 9802331 20557099 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
15.76 | 9802331 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
15.76 | 9802331 |
MESH:D009765 |
Obesity |
|
Ascorbic Acid |
8.32 | 17217161 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
8.32 | 11836018 18674790 16723640 19632207 20132043 20518802 17217161 21332399 18457598 |
MESH:D009765 |
Obesity |
|
Fructose |
8.32 | 17707055 18585860 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
8.32 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
6.54 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
6.54 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
4.61 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.71 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
12.61 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
12.61 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
12.61 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.19 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.32 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.32 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.32 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
11.32 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.32 | 16936753 |
MESH:D010146 |
Pain |
|
Phenytoin |
5.00 | 15215642 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.00 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
6.48 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
6.48 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
6.48 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.42 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
3.82 | 19014385 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
4.62 | 11026799 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.36 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
14.07 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
14.07 | 11605937 12224865 |
MESH:D011014 |
Pneumonia |
|
Ozone |
14.07 | 18007984 18929643 18381685 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
4.35 | 9212184 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.19 | 16144296 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
6.81 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
6.81 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.04 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
11.87 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
11.87 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
11.87 | 16679765 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
4.61 | 10903871 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
3.98 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
8.14 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
8.14 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.48 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.48 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.48 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.48 | 18247401 16289102 16644109 12479363 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.48 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.48 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ketoconazole |
2.48 | 17404083 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
2.48 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.48 | 17804756 15767336 17636462 16731767 17718901 17675339 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
2.87 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
4.73 | 12752131 1419762 8603615 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.88 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.99 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
3.99 | 10548101 |
MESH:D011649 |
Pulmonary Alveolar Proteinosis |
|
27-hydroxycholesterol |
5.58 | 15466366 |
MESH:D011654 |
Pulmonary Edema |
|
Oleic Acid |
4.99 | 15090967 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Ascorbic Acid |
4.52 | 14606601 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.77 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.01 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.01 | 17058453 16314181 15827377 17520802 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.34 | 18379247 11700416 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oleic Acid |
7.34 | 18549715 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.16 | 10835634 |
MESH:D012174 |
Retinitis Pigmentosa |
|
Ascorbic Acid |
3.02 | 16849425 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.35 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.20 | 16646077 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.73 | 16862918 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.38 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.38 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenytoin |
9.38 | 19919933 15946322 9844417 10029267 3137016 3691417 11044598 16876388 |
MESH:D012640 |
Seizures |
|
Toluene |
9.38 | 9294310 6431079 |
MESH:D012871 |
Skin Diseases |
|
Ascorbic Acid |
2.95 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.84 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
9.84 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.84 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.84 | 16467112 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
24-hydroxycholesterol |
10.79 | 11254748 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
27-hydroxycholesterol |
10.79 | 11254748 |
OMIM:270800 |
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE |
|
27-hydroxycholesterol |
5.57 | 19812052 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
4.37 | 20235791 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.53 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.73 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.73 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Docosahexaenoic Acids |
3.73 | 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.73 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ascorbic Acid |
5.34 | 18726076 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
5.34 | 15138204 |
MESH:D020521 |
Stroke |
|
Ascorbic Acid |
3.64 | 16403987 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.77 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.19 | 16684133 16045194 |
MESH:D013631 |
Tangier Disease |
marker/mechanism |
|
| |
MESH:D013733 |
Testicular Diseases |
|
Toluene |
4.16 | 10514026 10048760 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.46 | 15821434 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
5.11 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
5.11 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.87 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
7.56 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
7.56 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.17 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Rifampin |
6.58 | 15236969 18397238 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
6.58 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
11.54 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.54 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
11.54 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.54 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
11.54 | 16720314 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.34 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.34 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
7.18 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
7.18 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.19 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.38 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
3.80 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
9.07 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
9.07 | 1336536 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.53 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.29 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.05 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.27 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.63 | 17120751 |